TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04917120

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: The procedure will consist of a virtual reality program associated with suggestions of hypnoanalgesia, be added to usual care. Included patients will benefit from the Virtual Reality program combined with hypnoanalgesia suggestions for a period of 20 minutes. We will use a helmet with a built-in screen and an audio headset connected to a control room. Patients will watch an Virtual Reality sequence while listening to narratives designed for the hypnoanalgesia of the present pain.
Study: NCT05827718

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Method of Contact
Description: Behavioral Intervention studied here is the method of contact (text vs. email vs. email+text).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Method of Contact
Description: Behavioral Intervention studied here is the method of contact (text vs. email vs. email+text).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Method of Contact
Description: Behavioral Intervention studied here is the method of contact (text vs. email vs. email+text).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Source of Contact
Description: Behavioral Intervention studied here is source of contact (personal clinic vs. research team)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Source of Contact
Description: Behavioral Intervention studied here is source of contact (personal clinic vs. research team)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Framing Method (Appeal to Altruism or Social Proof
Description: Behavioral Intervention studied here is the framing methods appeal to altruism and social proof

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Framing Method (Appeal to Altruism or Social Proof
Description: Behavioral Intervention studied here is the framing methods appeal to altruism and social proof

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Incentive Structure
Description: Behavioral Interventions studied here are guaranteed vs. lottery incentives

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Incentive Structure
Description: Behavioral Interventions studied here are guaranteed vs. lottery incentives

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Incentive Structure
Description: Behavioral Interventions studied here are guaranteed vs. lottery incentives

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Incentive Structure
Description: Behavioral Interventions studied here are guaranteed vs. lottery incentives
Study: NCT04776239

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 100 million Allogeneic Mesenchymal Human Stem Cells
Description: 1 single intravenous infusion

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo delivered via peripheral intravenous infusion
Study: NCT04920175

Intervention type: OTHER
Intervention: Novel Real-time Neonatal Sleep Stage Detection Algorithm
Description: Comparison of Novel Real-time Neonatal Sleep Stage Detection Algorithm to gold standard concurrent polysomnogram.
Study: NCT06507358

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent-Child Interaction group
Description: The intervention for the Parent-Child Interaction group consists of a 6-week program involving weekly 40-minute sessions of therapeutic horticulture in a group setting, with 4-6 participants per group. The sessions focus on sensory-motor activities aimed at helping children engage in daily tasks and activities. Various sensory stimuli are provided through different materials used in gardening activities, including visual, auditory, gustatory, tactile, and olfactory stimuli. The program encourages mutual support and sharing among group members, showcases different outcomes, and emphasizes a sense of responsibility for home care. With a family-centered approach, parental involvement serves as a mediator to promote children's overall development and abilities. Participants are required to complete homework assignments and maintain activity records, including documentation of the 6 sessions through photos and written records.
Study: NCT05791006

Intervention type: BEHAVIORAL
Intervention: Neuropsychological tests
Description: Neuropsychological assessment with:~* NADL-F~* Frontal Assessment Battery (FAB)~* functional scales assessing activities of daily living (ADL) and instrumental activities of daily living (I-ADL)~* Mini-Mental Parkinson (MMP) - For Parkinson's Disease patients~* Montreal Cognitive Assessment (MoCA) - for brain tumor and stroke patients

Intervention type: BEHAVIORAL
Intervention: Neuropsychological tests
Description: Neuropsychological assessment with:~* NADL-F~* Frontal Assessment Battery (FAB)~* functional scales assessing activities of daily living (ADL) and instrumental activities of daily living (I-ADL)~* Mini-Mental Parkinson (MMP) - For Parkinson's Disease patients~* Montreal Cognitive Assessment (MoCA) - for brain tumor and stroke patients

Intervention type: BEHAVIORAL
Intervention: Neuropsychological tests
Description: Neuropsychological assessment with:~* NADL-F~* Frontal Assessment Battery (FAB)~* functional scales assessing activities of daily living (ADL) and instrumental activities of daily living (I-ADL)~* Mini-Mental Parkinson (MMP) - For Parkinson's Disease patients~* Montreal Cognitive Assessment (MoCA) - for brain tumor and stroke patients

Intervention type: BEHAVIORAL
Intervention: Neuropsychological tests
Description: Neuropsychological assessment with:~* NADL-F~* Frontal Assessment Battery (FAB)~* functional scales assessing activities of daily living (ADL) and instrumental activities of daily living (I-ADL)~* Mini-Mental Parkinson (MMP) - For Parkinson's Disease patients~* Montreal Cognitive Assessment (MoCA) - for brain tumor and stroke patients
Study: NCT05272657

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: low-carbohydrate diet
Description: subjects in this arm are given detailed instructions and coaching in following a low-carbohydrate diet.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Description: subjects in this arm are given detailed instructions and coaching in following a Mediterranean diet.
Study: NCT05673889

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARV-471
Description: Experimental

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate
Description: Probe substrate
Study: NCT05944029

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Pomegranate seed powder
Description: 10 g powder / day
Study: NCT05154071

Intervention type: OTHER
Intervention: Collection of medical data
Description: Collection of adverse events, of mortality, length of hospitalization

Intervention type: OTHER
Intervention: Collection of medical data
Description: Collection of adverse events, of mortality, length of hospitalization
Study: NCT06506292

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab
Description: Adebrelimab:1200 mg, iv, d1

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XELOX
Description: oxaliplatin: 130 mg/m2,iv,d1; capecitabine: 1000 mg/m2,po,pid,d1-d14
Study: NCT05177289

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Theradome® LH80 pro
Description: The Theradome LH80 pro is a wearable laser helmet device, which uses red laser light to stop hair loss, thicken existing hair and stimulate the growth of new hair.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Scalp cooling
Description: Scalp cooling is a standard treatment that is applied to prevent hair loss during chemotherapy.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Scalp cooling
Description: Scalp cooling is a standard treatment that is applied to prevent hair loss during chemotherapy.
Study: NCT06066606

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vilanterol and Fluticasone Furoate (low dose)
Description: Participants are administered 25 µg of vilanterol + fluticasone furoate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vilanterol and Fluticasone Furoate (high dose)
Description: Participants are administered 100 µg of vilanterol + fluticasone furoate

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants are administered placebo
Study: NCT06153199

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-management videos
Description: Short video modules on self-management of back pain without medication and ergonomic adjustments for limiting back pain in nursery and landscape work

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-management videos
Description: Short video modules on self-management of back pain without medication and ergonomic adjustments for limiting back pain in nursery and landscape work

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Check lists for ergonomic options
Description: Guidance on ergonomic choices appropriate for work tasks not currently being used that are the most difficult due to back pain, using a checklist

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text reminders
Description: Reminders to implement choices using graphics and gifs as well as motivational messages

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video review
Description: Participants will review videos of their movement during their most difficult work tasks to help problem solving to adjust ergonomic adjustments
Study: NCT05543733

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home exercise program
Description: Participants will complete a 6-month prescription telemedicine-based structured home exercise program. Baseline information will be used to develop a personalized home exercise program. This program will involve downloading the MyDataHelps application on a mobile device to securely collect wearable device information like step counts, activity minutes, and heart rate. Additionally, participants will have multiple virtual visits as well as the 2 in-person visits.
Study: NCT04380363

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Honda Walk Assist (HWA) device
Description: Use of HWA for 2 months in the home setting

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: SRALab fitness center membership
Description: Membership to Shirley Ryan AbilityLab fitness center for 2 months
Study: NCT05986591

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Test Product - Tiotropium Bromide Inhalation Powder 18 mcg
Description: Test Product

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Spiriva Handihaler (Tiotropium Bromide) 18 mcg
Description: RLD

Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo Product
Study: NCT04689555

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Novel method without manual compression
Description: Novel method for femoral artery hemostasis without manual compression. After sheath removal, four or five sterile gauzes were overlaid layer by layer and then bandaged without the procedure of manual compression.
Study: NCT05457400

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ENSO 16
Description: 30 g ENSO 16 dissolved in Water

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glucose Powder
Description: 30 g Glucose Powder dissolved in Water
Study: NCT04689555

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard method with manual compression.
Description: Standard method for femoral artery hemostasis with manual compression.After sheath removal, manual compression was continued for at least 10 minutes or until hemostasis. After that four or five sterile gauzes were overlaid layer by layer and then bandaged without the procedure of manual compression.
Study: NCT06396065

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK112 Injection
Description: Subjects will receive AK112 Plus Pemetrexed and Carboplatin via intravenous infusion (IV) Q3W, up to 4 cycles. Afterward, AK112 Plus Pemetrexed will be used for maintenance treatment (administered on Day 1 of each cycle, Q3W) up to 2 years.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo Injection
Description: Subjects will receive Placebo Plus Pemetrexed and Carboplatin via intravenous infusion (IV) Q3W, up to 4 cycles in treatment periods per the randomization schedule. Afterward, Placebo Plus Pemetrexed will be used for maintenance treatment (administered on Day 1 of each cycle, Q3W) up to 2 years.
Study: NCT05428540

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Polyphenol-rich supplement
Description: Polyphenol-rich capsules containing 1,200 mg of a combination of plant extracts rich in polyphenols. Frequency: 3 capsules a day. Duration: 12 weeks.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT05843617

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Liposomal Vitamin C
Description: 1000 mg of ascorbic acid in liposomal formulation

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Vitamin C
Description: 1000 mg of ascorbic acid in traditional formulation
Study: NCT06266871

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SOX+Tislelizumab+LDRT
Description: All patients will start with one cycle of neoadjuvant therapy of SOX plus tislelizumab regimen: S-1: 40-60 mg Bid, d1-14, q3w; oxaliplatin: 130 mg/m2, iv drip, d1, q3w; tislelizumab: 200 mg, iv drip, d1, q3w.~LDRT will be performed in the target area. After radiotherapy, patients will receive another two cycles of SOX plus tislelizumab.~Radical D2 gastric cancer resection will be performed 4-6 weeks after the last administration of SOX plus tislelizumab.~The adjuvant therapy will start in 4-6 weeks after the surgery, and we recommend adjuvant treatment with SOX regimen for up to 5 cycles.
Study: NCT06450223

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Perampanel 12 MG
Description: 1 tablet of Perampanel Tablets 12 mg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fycompa 12 mg film-coated tablets
Description: 1 tablet of Perampanel Tablets 12 mg
Study: NCT05616039

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Liver Surgery
Description: Standard liver surgery using naked eye examination +/- palpation and intra-operative ultrasound scan (IOUS) examination to identify and remove liver tumours

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Standard Liver Surgery
Description: Standard liver surgery using naked eye examination +/- palpation and intra-operative ultrasound scan (IOUS) examination to identify and remove liver tumours

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Indocyanine Fluorescent Image Guided Surgery (I-FIGS)
Description: Use of I-FIGS in accurate identification of tumours and their margins
Study: NCT05531513

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) Meditation
Description: The VR-Meditation intervention comprises an evidence-based 360-degree high-definition video VR application incorporating elements of nature, mindfulness and compassion. The VR-Meditation intervention is 4 weeks long and includes includes 4 different themes during the course of the program. Each week will focus on a distinct theme and will consist of two 20-minute VR sessions starting with a 10-minute guided meditation related to the weekly theme (one new meditation per week), followed by 10 minutes of open exploration of the virtual environment, for a total of 8 distinct sessions. The weekly themes are as follows:~* Week 1 - Mindfulness of the Environment~* Week 2 - Embodied Mindfulness~* Week 3 - Embodied and Embedded Compassion~* Week 4 - Mindfulness, Compassion, and the External Environment~In addition to baseline measures, participants in the VR Meditation condition will be asked to complete measures at mid-point (week 3), post-intervention (week 5), and follow-up (week 9).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducational Pamphlet
Description: The Psychoeducational Pamphlet intervention is 4 weeks long. Participants receive 1 pamphlet per week for a total of 4 different pamphlets. Handouts will provide information about managing stress and enhancing well-being, without referencing nature, mindfulness or compassion (e.g., eating habits, sleep hygiene, relaxation training, art exercises). The handouts will be based on empirical findings and will be written in accessible language with visual charts and specific practices to facilitate their implementation by participants. At the end of the study (i.e., after follow-up), Psychoeducation Pamphlet participants will receive access to the VR-Meditation program.~In addition to baseline measures, participants in the Psycho-educational Pamphlet condition will be asked to complete measures at mid-point (week 3), post-intervention (week 5), and follow-up (week 9).
Study: NCT05154565

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Guided meditation
Description: App-based guided meditation intervention through Headspace. This can be accessed through various mobile devices.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Guided meditation
Description: App-based guided meditation intervention through Headspace. This can be accessed through various mobile devices.
Study: NCT04541095

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EX_IMF
Description: Infant formula with large amounts of beta-palmitate (about 60%).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ST_IMF
Description: Infant formula with low amounts beta-palmitate (about 10%).
Study: NCT05900128

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: workshop
Description: Patients will receive workshops and they will encourage to practice physical activity

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: no workshop
Description: patients won't receive educative workshops
Study: NCT06216223

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: treatment of anal diseases in inflammatory bowel patients
Description: treatment of anal diseases in inflammatory bowel patients

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: treatment of anal diseases in inflammatory bowel patients
Description: treatment of anal diseases in inflammatory bowel patients

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Laser
Description: laser

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: traditional surgery
Description: traditional surgery
Study: NCT06355999

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Color Feedback
Description: Feedback is given about the correctness of the response on the color dimension

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Shape Feedback
Description: Feedback is given about the correctness of the response on the shape dimension
Study: NCT05944614

Intervention type: OTHER
Intervention: Magnetic Resonance imaging (MRI) examination
Description: 3D CINE and 4 dimensional (4D) flow MRI sequence

Intervention type: OTHER
Intervention: Magnetic Resonance imaging (MRI) examination
Description: 3D CINE and 4 dimensional (4D) flow MRI sequence
Study: NCT06082895

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Birth self-efficacy enhancement training based on motivational interviewing method
Description: Birth self-efficacy enhancement training based on motivational interviewing method
Study: NCT05564429

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-SF12051
Description: Injected intravenously followed by PET scanning

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-SF12051
Description: Injected intravenously followed by PET scanning
Study: NCT05458362

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Enhanced Anxiety Sensitivity Treatment (Group BEAST)
Description: Group BEAST consists of a 1.5-hour-long intervention session, followed by a 2-week-long EMI. During the intervention session, participants will receive psychoeducation (e.g., defining common terms like anxiety and stress), discuss popular misconceptions they may have about anxiety symptoms, and complete exposure exercises (e.g., practicing facing feared physical sensations such as trembling or elevated heart rate). Homework exposure exercises will be completed by all participants. They will receive phone app reminders about completing homework.~Only the EMI group will receive EMI prompts and intervention.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control group Anxiety Sensitivity Treatment
Description: Control group Anxiety Sensitivity Treatment consists of a 1.5-hour-long intervention session, followed by a 2-week-long EMI. During the intervention session, participants will receive psychoeducation (e.g., defining common terms like anxiety and stress), discuss popular misconceptions they may have about anxiety symptoms, and complete exposure exercises (e.g., practicing facing feared physical sensations such as trembling or elevated heart rate). Homework exposure exercises will be completed by all participants. They will receive phone app reminders about completing homework.
Study: NCT01067651

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Plaster of Paris (POP) casting using the Ponseti Method

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Semi-Rigid Fiberglass softcast using the Ponseti Method
Study: NCT05564429

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-SF12051
Description: Injected intravenously followed by PET scanning
Study: NCT06118762

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fruquintinib
Description: Fruquintinib capsule is taken orally once a day, 5 mg each time, and taken for 2 weeks and stopped for 1 week, every 21 days (3 weeks) for a cycle. Raltitrexed: 3 mg/m2 intravenously, on the first day of each cycle, for a treatment cycle of 3 weeks. Combination treatment until toxicity becomes intolerable, disease progression, or death.
Study: NCT04949425

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adavosertib
Description: Patients will receive Adavosertib orally.
Study: NCT04628767

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo tissue biopsy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biopsy
Description: Undergo tissue biopsy